Maximum inspiratory pressure, a surrogate parameter for the assessment of ICU-acquired weakness by unknown
RESEARCH ARTICLE Open Access
Maximum inspiratory pressure, a surrogate
parameter for the assessment of ICU-acquired
weakness
Georgios Tzanis, Ioannis Vasileiadis, Dimitrios Zervakis, Eleftherios Karatzanos, Stavros Dimopoulos,
Theodore Pitsolis, Elli Tripodaki, Vasiliki Gerovasili, Christina Routsi and Serafim Nanas*
Abstract
Background: Physical examination has been advocated as a primary determinant of ICU-acquired weakness (ICU-
AW). The purpose of the study is to investigate ICU-AW development by using Maximum Inspiratory Pressure (MIP)
as a surrogate parameter of the standardized method to evaluate patients’ peripheral muscle strength.
Methods: Seventy-four patients were recruited in the study and prospectively evaluated in a multidisciplinary university
ICU towards the appearance of ICU-AW. APACHE II admission score was 16 ± 6 and ICU stay 26 ± 18 days. ICU-AW was
diagnosed with the Medical Research Council (MRC) scale for the clinical evaluation of muscle strength. MIP was
measured using the unidirectional valve method, independently of the patients’ ability to cooperate.
Results: A significant correlation was found between MIP and MRC (r = 0.68, p < 0.001). Patients that developed
ICU-AW (MRC<48) had a longer weaning period compared to non ICU-AW patients (12 ± 14 versus 2 ± 3 days, p
< 0.01). A cut-off point of 36 cmH2O for MIP was defined by ROC curve analysis for ICU-AW diagnosis (88%
sensitivity,76% specificity). Patients with MIP below the cut-off point of 36 cmH2O had a significant greater
weaning period (10 ± 14 versus 3 ± 3 days, p = 0.004) also shown by Kaplan-Meier analysis (log-rank:8.2;p = 0.004).
Conclusions: MIP estimated using the unidirectional valve method may be a potential surrogate parameter for the
assessment of muscle strength compromise, useful for the early detection of ICU-AW.
Background
ICU-acquired weakness (ICU-AW) is a well recognised
complication, with an incidence of 10-25%, among long-
term mechanically-ventilated patients [1-5]. ICU-AW
presents with profound muscle weakness and difficulty
to wean from mechanical ventilation (MV); it results in
prolonged Intensive Care Unit (ICU) and hospital stay
and even in increased mortality [6,7]. Clinical, electro-
physiological and histological approaches have been
used for the diagnosis [2,8,9]. Clinical detection is based
on the assessment of skeletal muscle weakness. A stan-
dardized and reliable method to evaluate limb muscle
groups is the Medical Research Council (MRC) muscle
strength score [10-12] which has been used for the diag-
nosis of ICU-AW [2,9,13-15].
Although ICU-AW was firstly described in patients with
prolonged time to successful weaning from the ventilator
[16], specific estimation of respiratory muscle strength
reduction in the context of this neuromuscular disorder
has been addressed only in a recent study by De Jonghe et
al [17]. This study confirmed the association between
respiratory muscle and skeletal muscle weakness using the
standard methodology of measuring respiratory pressures.
Previous studies have shown that systemic diseases
with peripheral muscle involvement also affect the
respiratory muscles, reducing the pressures developed
during respiration [18].
The clinical detection of ICU-AW by MRC muscle
strength score appraisal as well as fully informative
study of respiratory dynamics presupposes that patients
have sufficient level of consciousness to cooperate and
respond to orders [10,11]. A method to assess muscle
strength in patients that are not yet able to cooperate
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after critical illness recovery has not been described so
far. Furthermore, the time required for the patient to
regain consciousness seems nevertheless precious in
terms of possible early beneficial precautions and inter-
ventions that could lessen the probability of developing
clinically significant neuromyopathy.
Our hypothesis was that ICU-AW could equally affect
respiratory muscles, as the peripheral muscles of the
limbs, resulting in reduced respiratory muscle strength
and diminished inspiratory pressure developed during
the respiratory efforts. Assessment of respiratory muscle
strength in the critically ill patients before they fully
recover could be an alternative method for the early
detection of ICU-AW.
The aim of this study is to investigate a surrogate
index of ICU-AW by estimating inspiratory muscle
strength with the unidirectional valve technique that can




The study was approved by the Scientific Council and
the Ethics Committee of our Hospital. Family members
of all patients that were included in the study gave writ-
ten informed consent.
Seventy-four patients with ICU stay ≥ 7 days, were
recruited in the study and prospectively evaluated in a
multidisciplinary university ICU towards the appearance
of ICU-AW. Exclusion criteria were age < 18 yrs, presence
of pregnancy, limb fractures, body-mass index > 35 kg/m2
and known pre-existing causes of neuromuscular weak-
ness. Patients characteristics are presented in Table 1.
Design of the study
All patients that fulfilled the inclusion criteria were
thoroughly followed-up during the ICU stay. Assessment
of illness severity on admission was performed by the
APACHE II, SOFA and SAPS II prognostic scores
[19-21]. Trials of weaning from the ventilatory support
were started after daily clinicians’ decision according to
the patient’s clinical conditions. All patients underwent
an assessment of respiratory muscle strength by mea-
surement of maximum inspiratory pressure (MIP) after
a 48 hours discontinuation of sedation and MRC muscle
strength scale when patients regained consciousness, if
possible within 48 hours from MIP measurements.
Maximum inspiratory pressure
MIP was measured with the method described by Marini
et al [22] where a unidirectional expiratory valve is used to
selectively permit exhalation while inspiration is blocked.
One side of the valve was attached to the patient’s endo-
tracheal tube and the other side to a manometer.
Manometer could register pressures from 0 to 100 cmH20.
Patients were disconnected from the ventilator and were
attached to the valve for a period of more than 30 sec and
the maximal value was recorded. Three maneuvers were
performed and the highest value was used for the analysis.
Conduction of this process does not require the coordina-
tion of the patient whereas it permits MIP assessment at
lung volumes progressively closer to residual volume. In
an effort to allow respiratory drive reappearance, MIP
assessment was performed approximately 48 hours after
the discontinuation of sedation.
MRC muscle strength scale
The patients were assessed on a regular basis for the
development of neuromuscular weakness. The MRC
scale for clinical assessment of muscle strength [10-12]
was used for the diagnosis of ICU-AW with values
Table 1 Characteristics of critically ill patients evaluated
for inspiratory muscle strength that enrolled in the study
(N = 74) and of the above critically ill patients that MRC
muscle strength score could be estimated (N = 33)
Variables N = 74 N = 33
Age, years 59 ± 20 55 ± 20
Gender, Male/Female 52/22 29/4
COPD 10 5
Chronic heart failure 4 3







Cerebral hemorrhage/surgery 14 4
Cardiothoracic/Vascular surgery 4 2
Abdominal surgery 10 7
Drug intoxication 1 1
Other 12 5
ICU Stay, days 33 ± 17 32 ± 18
APACHE II score 16 ± 5 15 ± 5
SOFA score 8 ± 3 7 ± 3
SAPS III score 57 ± 14 55 ± 12
ICU-AW/no ICU-AW 17/16
MRC muscle strength score, (n = 33) 41 ± 16
MIP, cmH2O 37 ± 18 38 ± 17
Length of MV until onset of weaning, days, (n = 66/
31)
16 ± 13 13 ± 12
Weaning period, days, (n = 60/30) 6 ± 10 7 ± 11
COPD = Chronic obstructive pulmonary disease, ICU = Intensive Care Unit,
APACHE = Acute Physiology and Chronic Health Evaluation, SOFA =
Sequential Organ Failure Assessment, SAPS = Simplified Acute Physiology,
ICU-AW = ICU acquired weakness, MRC = Medical Research Council, MIP =
Maximum inspiratory pressure, MV = Mechanical ventilation.
All continuous variables are presented as mean ± SD
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ranging from 0 (quadriplegia) to 60 (normal muscle
strength) and with a score of 48 being the cut off point
for the diagnosis of ICU-AW. We adopted a cut off
limit of 48 for the MRC score because it reflects clini-
cally significant weakness and has been used previously
for the clinical identification of ICU-acquired paresis [2].
MRC score was performed by two independent investi-
gators that were familiar with this technique. MRC was
obtained on the day the patients had level of conscious-
ness adequate to respond to at least three of these
orders ("open/close your eyes”, “look at me”, “put out
your tongue”, “nod your head”, “raise your eyebrows”).
Weaning from mechanical ventilation
T-piece trial was used as a screening method for weaning
after daily clinical evaluation. Weaning period was
defined as the time from the onset of weaning trials until
the day there was no need for MV for the next 48 hours.
Weaning was considered successful when no ventilatory
support was necessary for at least two days. The duration
of MV, the duration of onset of MV to onset of weaning
and the duration of weaning period were all recorded.
Statistical analysis
All continuous variables are presented by mean ± SD.
Group means of continuous variables were compared by
unpaired Student’s t-test. The association between MIP
and MRC muscle strength score was analyzed by Pear-
son’s correlation coefficient. The cut-off value for MIP
to predict ICU-AW was based on receiver operating
characteristic (ROC) curve analysis. The Kaplan-Meier
method was used to compare the duration of weaning
between patients with and without ICU-AW and to
compare weaning period between patients that had MIP
below or above the cut-off value. We compared the two
groups using the log-rank test. The lowest level for sta-
tistical significance was set at p < 0.05.
Results
Patients’ characteristics enrolled in the study are reported
in Table 1. From the 74 patients, 8 patients died without
reaching the weaning period and 5 patients died after
weaning process. One patient was transferred to another
ICU after a long period of weaning trials. Sixty patients
were successfully weaned from the ventilator.
The mean value of MIP in the critically ill patients (N =
74) tested was 37 ± 18 cmH2O. Among the 74 patients
enrolled in the study 39 patients did not have a sufficient
level of consciousness for the assessment of limb muscle
strength by the MRC score and the diagnosis of ICU-AW
could not be established. This group consisted of 14 patients
that died and 25 patients that never regained a sufficient
level of consciousness until the discharge from the ICU.
Two patients were overlooked and MRC was not estimated.
Consequently MRC was safely estimated in 33 patients and
its mean value was 38 ± 17. The mean time difference
between MIP and MRC testing was 5 ± 5 days. Characteris-
tics of patients with MRC muscle strength score evaluation
are presented in Table 1. From these patients, three patients
died before weaning period started and 30 patients were
successfully weaned from mechanical ventilation.
A significant correlation between MIP and MRC mus-
cle strength score was found in the core material of 33
patients that were amenable to both measurements (r =
0.68, p < 0.001, Figure 1).
Patients that developed clinically ICU-AW (51%) had
a longer ICU stay (41 ± 19 versus 21 ± 11, days, p =
0.001), a lower MIP (28 ± 15 versus 49 ± 11, cmH2O, p
< 0.001), and a longer MV weaning period (12 ± 14 ver-
sus 2 ± 3, days, p < 0.05).
The value of 36 cmH2O for MIP was found as the
best cut-off value for the diagnosis of ICU-AW from the
ROC curve analysis [AUC (area under the curve) = 0.85;
CI:0.71-0.99, p = 0.001)]. The value of 36 cmH2O had a
sensitivity of 88% and a specificity of 76% for the diag-
nosis of ICU-AW.
In a prospective analysis of the 74 patients included in
the study, patients with MIP < 36 cmH2O were older
(67 ± 16 versus 51 ± 7, years, p = 0.001), had a more
severe APACHE II and SAPS III score [(17 ± 4 versus
15 ± 5, p = 0.05) and (62 ± 14 versus 53 ± 12, p =
0.05), respectively], a longer ICU stay (37 ± 6 versus 28
± 13, days, p = 0.001), and a longer MV weaning period
(10 ± 14 versus 3 ± 3, days, p < 0.01).
Kaplan-Meier analysis
Patients with ICU-AW had a greater daily probability of
remaining under mechanical ventilation (MV) after the
Figure 1 Scattergram of maximum inspiratory pressure and
medical research council scale for muscle strength in critical ill
patients enrolled in the study, (r:0.68; p < 0.001, N = 33).
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onset of weaning compared with those patients without
ICU-AW (log-rank:6.2; p = 0.01, Figure 2).
Similarly, patients with MIP < 36 cmH2O had a
greater daily probability of remaining under mechanical
ventilation (MV) after the onset of weaning compared
with those patients with MIP ≥ 36 cmH2O (log-
rank:8.2; p = 0.004, Figure 3).
Discussion
Our study showed that MIP in critically ill patients sig-
nificantly correlated with the MRC muscle strength
score which estimates peripheral muscle strength.
Generalized, peripheral neuromyopathies can affect
respiratory muscles and reduce respiratory pressures
[18]. Chronic heart failure is a syndrome in which per-
ipheral myopathy is characterized by skeletal muscle
dysfunction, including the respiratory muscles [23,24].
There is a relationship between respiratory muscle
strength and the oxidative capacity of the skeletal mus-
cles in heart failure [25], indicating a correlation
between the peripheral and the respiratory muscles.
De Jonghe et al [17] measured maximum inspiratory
and expiratory pressures in critically ill patients on the
first day of return to normal consciousness. The same
day MRC muscle strength score was assessed. They dis-
covered frequent alterations in the above mentioned
variables of respiratory neuromuscular function. They
also found a significant correlation between limb and
respiratory muscle strength possibly suggesting a com-
mon basic pathophysiologic process which results in the
noted limb and respiratory muscle weakness.
In our study we found a stronger correlation between
MIP and MRC muscle strength score (r = 0.68 in our
study vs r = 0.35 in the afore-mentioned study). Anxiety
and inadequate collaboration up on the perception of
the discontinued ventilatory support and/or the different
method for MIP measurement might partly explain the
difference. MIP value depends, among other factors,
upon the lung volume when inspiratory effort begins.
The use of the unidirectional valve (as in our study) per-
mits MIP assessment at lung volumes progressively clo-
ser to residual volume, so that the patient can generate
the greatest negative force while inspiring against the
occluded airway and the measurement of maximal
inspiratory muscle strength can be attained. This techni-
que yields more reproducible, consecutive measure-
ments and discloses values probably nearer the real MIP
[26,27]. Its larger values could lessen the coefficient of
variation.
In our study it was also demonstrated that MIP can
predict weaning period from MV in the ICU, even in
patients that could not cooperate. Both patient groups,
with ICU-AW classified by the MRC score for muscle
strength and patients with MIP below the cut-off point
of 36 cmH2O, exhibited similarly prolonged weaning
from the ventilator, supporting further the clinical rele-
vance of MIP measurement in the critically ill, in regard
to the ICU-AW.
Previous studies established a strong association
between limb neuromuscular involvement and duration
of mechanical ventilation. Addressing the question of
whether ICU-AW prolongs mechanical ventilation and
weaning time or if this prolongation is the effect of con-
current risk factors of weaning failure Garnacho-Mon-
tero et al [6], demonstrated that ICU-AW is an
Figure 2 Kaplan-Meier curves of the probability of remaining
under mechanical ventilation (MV) after the onset of weaning
according to the presence or not of ICU-acquired weakness
(ICU-AW). A cut off limit of 48, for the medical research council
scale (MRC) muscle strength score, has been adopted for the
diagnosis of ICU-AW.
Figure 3 Kaplan-Meier curves of the probability of remaining
under mechanical ventilation (MV) after the onset of weaning
according to maximum inspiratory pressure (MIP < or ≥ 36
cmH2O).
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independent cause of weaning failure. Direct impact of
ICU-AW on weaning duration was also previously
demonstrated by De Jonghe et al [28]. In this study
respiratory muscle weakness was associated with delayed
extubation and prolonged ventilation [17]. Unlike the
above mentioned study, in our study respiratory muscle
assessment with MIP was also performed in patients
that did not cooperate, providing information about
weaning period and length of MV in this group of
patients.
It has been shown that MIP can accurately be
recorded in poorly cooperative patients when a unidirec-
tional valve is used to occlude the airway, provided ade-
quate respiratory drive is achieved [29]. In our study
this method exhibited a very good ability to correctly
classify those with and without ICU-AW.
Current approaches for ICU-AW diagnoses comprise
physical motor examination and electrophysiological
investigations. Physical examination is dependent on
patient’s cooperation and maximal effort. A reliable
assessment of neuromuscular function (e.g. with MRC
score determination) cannot be performed in patients
not fully awake or when cognitive function is not intact.
Under these circumstances ICU-AW diagnosis, or
generally neuromuscular dysfunction evaluation, relies
on electrophysiological studies (motor and sensory
nerve conduction studies, electromyography) [8,30-34]
and electrical or magnetic nerve stimulation to measure
isotonic or isometric limb muscle strength [35]. More-
over conventional signs of ICU-AW may be absent and
electrophysiological studies could help establish the
diagnosis. However, several limitations exist and also
risks and costs of this testing should be taken into
account. Conventional electrodiagnostic techniques
often provide non-specific results or are hampered by
local conditions (edema, multiple electrical devices) that
prevent adequate disease classification [36]. Additionally,
literature results are controversial regarding the estima-
tion of ICU stay by electrophysiological studies. Witt et
al found a negative correlation between the time of ICU
stay and the peripheral nerve function as assessed by
electrophysiological studies [33], whereas, in a more
recent study, neurophysiologic testing results failed to
predict duration of ICU stay or ventilation; it looks that
they merely duplicate the diagnosis with no improve-
ment to management or outcome prediction [37].
Advanced and invasive diagnostic procedures that
require expertise in testing performance and interpreta-
tion are usually applied when patients exhibit not easily
explained focal deficits or persistently altered sensorium.
Therefore physical examination has been advocated as a
primary determinant of ICU-AW [2].
Our study showed that MIP may be useful for periph-
eral muscle strength evaluation and ICU-AW
identification in the critically ill, supporting its applica-
tion in diagnostic decision making even when patients
are unable to cooperate. It could be possibly considered
as a screening test for ICU-AW as it can be performed
earlier and in patients not fully awake, unlike MRC.
Several clinical implications exist. A reliable identifica-
tion of this potentially reversible complication leads to
most accurate predictions about a patient with pro-
tracted critical illness, which could alter the intensity of
management [38]. Additionally early detection of the
disease may force physicians and generally health provi-
ders to more consistently avoid precipitating factors. A
recent study held in our institution addressed that elec-
tro muscular stimulation of muscles of lower extremities
prevents the development of ICU-AW in critically ill
patients and also results in shorter duration of weaning
[39], indicating that therapeutic interventions could be
applied earlier, possibly influencing outcome in terms of
length of hospitalization, long term prognosis and mor-
tality which are aggravated by the presence of ICU-AW.
Limitations
A limitation of our study is the limited number of
patients that eventually regained consciousness and
were evaluated by both the MRC scale and MIP. The
lack of an electrophysiological investigation is a limita-
tion of the study and should be kept in mind when
interpreting the significance of the results of this study.
However we suggested MIP as a surrogate parameter of
MRC muscle strength scale that is also a clinical
approach for the detection of ICU-AW. Another limita-
tion is that the results of the present study, specifically
the ROC curve analysis and the AUC, which disclose
the diagnostic accuracy of the utilized method, are
based on the MIP and MRC score estimation in the
selected group of patients that finally recovered, which
questions the broader application of this method in all
ICU patients (meaning in the non-recovering group). As
there is not though so far a gold standard method for
clinically relevant ICU-AW discrimination other than
the physical assessment that requires patient coopera-
tion and maximal effort, this is a general problem one
encounters while attempting a non-invasive evaluation
of patients with permanently reduced consciousness and
comprehension. Finally, although we did not assess ven-
tilatory drive before MIP assessment, forcing patients to
boost a possibly insufficient ventilatory drive (add dead
space for instance) would have resulted in even greater
MIP values.
Conclusions
In conclusion, measurement of MIP, utilizing the unidir-
ectional valve method, in critically ill patients, may be
used as a diagnostic tool for the early detection of ICU-
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AW even in patients that have not regained conscious-
ness. Further investigations addressing the broad appli-
cation of the method are required.
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